Search

Your search keyword '"Priori, A"' showing total 506 results

Search Constraints

Start Over You searched for: Author "Priori, A" Remove constraint Author: "Priori, A" Topic internal medicine Remove constraint Topic: internal medicine
506 results on '"Priori, A"'

Search Results

1. Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort

2. Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study

3. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

4. Resilience in women with primary Sjögren’s syndrome

5. Evolving determinants of carotid atherosclerosis vulnerability in asymptomatic patients from the MAGNETIC observational study

6. Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)

7. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjogren's syndrome

8. Arrhythmic Mitral Valve Prolapse: Introducing an Era of Multimodality Imaging-Based Diagnosis and Risk Stratification

9. Cardiac ryanodine receptors: is a severe loss-of-function not so severe after all?

10. Additional diagnostic value of cardiac magnetic resonance feature tracking in patients with biopsy-proven arrhythmogenic cardiomyopathy

11. SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients

12. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

13. Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease

14. Limbic neurochemical changes in patients with functional motor symptoms

15. Comparison of early vs. delayed anakinra treatment in patients with adult onset still's disease and effect on clinical and laboratory outcomes

16. An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition

17. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

18. A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial

19. Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation

20. Time-to-first appropriate shock in patients implanted prophylactically with an implantable cardioverter-defibrillator: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS)

21. Identification of loss-of-function RyR2 mutations associated with idiopathic ventricular fibrillation and sudden death

22. Peripheral Nervous System Involvement in Sjögren’s Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren’s Syndrome

23. Cardiac ryanodine receptor calcium release deficiency syndrome

24. The Many Faces of COVID-19 at a Glance: A University Hospital Multidisciplinary Account From Milan, Italy

25. Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients

26. Rheumatic Diseases in the Elderly

27. Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome)

28. Is mexiletine ready for prime time in patients with Type 2 Long QT Syndrome?

29. The truly forgotten chamber: prognostic value of right atrial dilation in patients with sinus rhythm and significant functional tricuspid regurgitation

30. Mutation site-specific risk profile in patients with Type 1 Long QT Syndrome

31. Automated screening tool for Subcutaneous Implantable Defibrillator in Brugada syndrome has a high eligibility rate which is predicted by simple electrocardiographic parameters

32. Characterization of arrhythmic presentation in patients with arrhythmogenic cardiomyopathy

33. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

34. Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real life clinical practice: a nationwide multicenter retrospective observational study

35. Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1

36. Efficacy and Limitations of Quinidine in Patients With Brugada Syndrome

37. Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts

38. Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response

39. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

40. An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica

41. Cerebrospinal fluid glutamate changes in functional movement disorders

42. Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy

43. Application of a staging model in patients with obsessive compulsive disorder: Cross-sectional and follow-up results

44. Erratum. management of adult-onset still's disease with interleukin-1 inhibitors. evidence- and consensus-based statements by a panel of Italian experts

45. Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19

46. J-Wave Syndromes

47. Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study

48. Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada Syndrome

49. Suppression of Arrhythmia by Enhancing Mitochondrial Ca2+ Uptake in Catecholaminergic Ventricular Tachycardia Models

50. Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3

Catalog

Books, media, physical & digital resources